ID

18144

Description

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00087867

Link

https://clinicaltrials.gov/show/NCT00087867

Keywords

  1. 10/23/16 10/23/16 -
Uploaded on

October 23, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00087867

Eligibility Multiple Myeloma NCT00087867

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
life expectancy more than three months
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
diagnosed with multiple myeloma (mm)
Description

Multiple Myeloma

Data type

boolean

Alias
UMLS CUI [1]
C0026764
relapsed following a response to any conventional mm therapy, and refractory to their most recent mm therapy
Description

Conventional Treatment Multiple Myeloma Response | Recurrent disease | Therapeutic procedure Recent Multiple Myeloma Unresponsive to Treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C2945704
UMLS CUI [1,2]
C0026764
UMLS CUI [1,3]
C1704632
UMLS CUI [2]
C0277556
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0332185
UMLS CUI [3,3]
C0026764
UMLS CUI [3,4]
C0205269
karnofsky performance status = 60
Description

Karnofsky Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C0206065
no electrocardiographic evidence of acute ischemia or new conduction system abnormalities
Description

Ischemia | Conduction system abnormalities New | Electrocardiography Evidence

Data type

boolean

Alias
UMLS CUI [1]
C0022116
UMLS CUI [2,1]
C0151236
UMLS CUI [2,2]
C0205314
UMLS CUI [3,1]
C1623258
UMLS CUI [3,2]
C3887511
no history of myocardial infarction within last 6 months
Description

Myocardial Infarction

Data type

boolean

Alias
UMLS CUI [1]
C0027051
serum concentrations of aspartate aminotransferase (ast) and alanine aminotransferase (alt) = 3x upper limit of normal (uln)
Description

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
total serum bilirubin = 2x uln
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
calculated or measured creatinine clearance >30 ml/min
Description

Estimation of creatinine clearance by Cockcroft-Gault formula | Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C2711451
UMLS CUI [2]
C0373595
platelet count = 30 x 10(9)/l
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
hemoglobin concentration = 8 g/dl
Description

Hemoglobin

Data type

boolean

Alias
UMLS CUI [1]
C0019046
white blood cell count = 2.0 x 10(9)/l
Description

White Blood Cell Count procedure

Data type

boolean

Alias
UMLS CUI [1]
C0023508
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with non-secretory myeloma, plasma cell leukemia, or poems syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, m-protein and skin changes)
Description

Non-secretory myeloma | Leukemia, Plasma Cell | POEMS Syndrome | Plasma cell dyscrasia with polyneuropathy | Organomegaly | Endocrine System Diseases | M Protein Change | skin; change

Data type

boolean

Alias
UMLS CUI [1]
C0456845
UMLS CUI [2]
C0023484
UMLS CUI [3]
C0085404
UMLS CUI [4]
C0272255
UMLS CUI [5]
C4054315
UMLS CUI [6]
C0014130
UMLS CUI [7,1]
C0700271
UMLS CUI [7,2]
C0392747
UMLS CUI [8]
C1399787
major surgery within four weeks of enrollment
Description

major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0679637
severe elevated serum calcium
Description

Serum calcium increased Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0595928
UMLS CUI [1,2]
C0205082
heart failure
Description

Heart failure

Data type

boolean

Alias
UMLS CUI [1]
C0018801
receipt of chemotherapy within 21 days before enrollment, receiving immunotherapy, radiation therapy, or other investigational agents
Description

Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0021083
UMLS CUI [3]
C1522449
UMLS CUI [4]
C0013230
receipt of corticosteroids equivalent to more than 10 mg/day of prednisone within two weeks before enrollment
Description

Adrenal Cortex Hormones | Prednisone

Data type

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2]
C0032952
known allergies to agents used in bortezomib (e.g., boron or mannitol)
Description

Hypersensitivity bortezomib | Hypersensitivity Boron | Mannitol allergy

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1176309
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0006030
UMLS CUI [3]
C0571922
poorly controlled hypertension, diabetes mellitus, or other serious medical or psychiatric illness that could potentially interfere with the completion of treatment according to this protocol
Description

Poor hypertension control | poorly controlled diabetes mellitus | Illness Serious Interferes with Protocol Compliance | Serious mental illness Interferes with Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C0421190
UMLS CUI [2]
C0554876
UMLS CUI [3,1]
C0221423
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C0521102
UMLS CUI [3,4]
C0525058
UMLS CUI [4,1]
C3841614
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0525058

Similar models

Eligibility Multiple Myeloma NCT00087867

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Life Expectancy
Item
life expectancy more than three months
boolean
C0023671 (UMLS CUI [1])
Multiple Myeloma
Item
diagnosed with multiple myeloma (mm)
boolean
C0026764 (UMLS CUI [1])
Conventional Treatment Multiple Myeloma Response | Recurrent disease | Therapeutic procedure Recent Multiple Myeloma Unresponsive to Treatment
Item
relapsed following a response to any conventional mm therapy, and refractory to their most recent mm therapy
boolean
C2945704 (UMLS CUI [1,1])
C0026764 (UMLS CUI [1,2])
C1704632 (UMLS CUI [1,3])
C0277556 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0332185 (UMLS CUI [3,2])
C0026764 (UMLS CUI [3,3])
C0205269 (UMLS CUI [3,4])
Karnofsky Performance Status
Item
karnofsky performance status = 60
boolean
C0206065 (UMLS CUI [1])
Ischemia | Conduction system abnormalities New | Electrocardiography Evidence
Item
no electrocardiographic evidence of acute ischemia or new conduction system abnormalities
boolean
C0022116 (UMLS CUI [1])
C0151236 (UMLS CUI [2,1])
C0205314 (UMLS CUI [2,2])
C1623258 (UMLS CUI [3,1])
C3887511 (UMLS CUI [3,2])
Myocardial Infarction
Item
no history of myocardial infarction within last 6 months
boolean
C0027051 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
serum concentrations of aspartate aminotransferase (ast) and alanine aminotransferase (alt) = 3x upper limit of normal (uln)
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Serum total bilirubin measurement
Item
total serum bilirubin = 2x uln
boolean
C1278039 (UMLS CUI [1])
Estimation of creatinine clearance by Cockcroft-Gault formula | Creatinine clearance measurement
Item
calculated or measured creatinine clearance >30 ml/min
boolean
C2711451 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Platelet Count measurement
Item
platelet count = 30 x 10(9)/l
boolean
C0032181 (UMLS CUI [1])
Hemoglobin
Item
hemoglobin concentration = 8 g/dl
boolean
C0019046 (UMLS CUI [1])
White Blood Cell Count procedure
Item
white blood cell count = 2.0 x 10(9)/l
boolean
C0023508 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Non-secretory myeloma | Leukemia, Plasma Cell | POEMS Syndrome | Plasma cell dyscrasia with polyneuropathy | Organomegaly | Endocrine System Diseases | M Protein Change | skin; change
Item
patients with non-secretory myeloma, plasma cell leukemia, or poems syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, m-protein and skin changes)
boolean
C0456845 (UMLS CUI [1])
C0023484 (UMLS CUI [2])
C0085404 (UMLS CUI [3])
C0272255 (UMLS CUI [4])
C4054315 (UMLS CUI [5])
C0014130 (UMLS CUI [6])
C0700271 (UMLS CUI [7,1])
C0392747 (UMLS CUI [7,2])
C1399787 (UMLS CUI [8])
major surgery
Item
major surgery within four weeks of enrollment
boolean
C0679637 (UMLS CUI [1])
Serum calcium increased Severe
Item
severe elevated serum calcium
boolean
C0595928 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Heart failure
Item
heart failure
boolean
C0018801 (UMLS CUI [1])
Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Investigational New Drugs
Item
receipt of chemotherapy within 21 days before enrollment, receiving immunotherapy, radiation therapy, or other investigational agents
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0013230 (UMLS CUI [4])
Adrenal Cortex Hormones | Prednisone
Item
receipt of corticosteroids equivalent to more than 10 mg/day of prednisone within two weeks before enrollment
boolean
C0001617 (UMLS CUI [1])
C0032952 (UMLS CUI [2])
Hypersensitivity bortezomib | Hypersensitivity Boron | Mannitol allergy
Item
known allergies to agents used in bortezomib (e.g., boron or mannitol)
boolean
C0020517 (UMLS CUI [1,1])
C1176309 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0006030 (UMLS CUI [2,2])
C0571922 (UMLS CUI [3])
Poor hypertension control | poorly controlled diabetes mellitus | Illness Serious Interferes with Protocol Compliance | Serious mental illness Interferes with Protocol Compliance
Item
poorly controlled hypertension, diabetes mellitus, or other serious medical or psychiatric illness that could potentially interfere with the completion of treatment according to this protocol
boolean
C0421190 (UMLS CUI [1])
C0554876 (UMLS CUI [2])
C0221423 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0521102 (UMLS CUI [3,3])
C0525058 (UMLS CUI [3,4])
C3841614 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0525058 (UMLS CUI [4,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial